TONYA BENNETT: Open Payments
NPI 1801378187 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$654 in 30 payments from 13 companies in 2025. Trend: 2023 $743 · 2024 $416 · 2025 $654
Food & beverage: $554Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $160 |
| Astellas Pharma US Inc | 2 | $115 |
| PFIZER INC. | 3 | $67 |
| Lilly USA, LLC | 3 | $64 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Corcept Therapeutics | 1 | $27 |
| ABBVIE INC. | 1 | $26 |
| Dexcom, Inc. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $24 |
Products named: Wegovy, MOUNJARO, LEQVIO, Ozempic, NURTEC ODT, Korlym, QULIPTA, PREVNAR 20.
Industry payments across CA — which companies pay providers there.
